Latest News | Granules Acquires Swiss Firm for Rs 192 Cr; Forays into CDMO Space

New Delhi, Feb 21 (PTI) Drug firm Granules India on Friday said it has acquired Switzerland-based CDMO firm Senn Chemicals AG for CHF 20 million (around Rs 192 crore).

Senn develops and manufactures, Peptides and Peptides-based applications for its global customers, providing contract research, development, and manufacturing (CDMO) services.

Also Read | News Headlines for School Assembly Today, 22 February 2025: Check Important National, International, Sports, Entertainment and Business Stories.

The acquisition is expected to be completed in the first half of 2025, Granules India said in a statement.

"By entering the rapidly growing peptide therapeutics segment and acquiring CDMO capabilities, we are expanding into next-generation therapeutics that align with our commitment to innovation and affordability," Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India, said.

Also Read | What Is Coffee Badging? All About Office Trend Becoming Popular As Companies Issue Return-to-Office Mandates.

Senn's expertise in peptide synthesis, coupled with company's large-scale, cost-efficient manufacturing capabilities, positions Granules to deliver high-quality peptide-based solutions globally, he added.

Rico Wiedenbruch, Chairman, Senn Chemicals AG, said "With Granules' scale, operational efficiency, and global reach in pharmaceuticals industry, we see strategic fit and tremendous potential to accelerate our growth and expand our capabilities in rapidly growing peptide therapeutics."

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)